Kyverna Therapeutics Newsroom

Morgan Stanley Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Maintains Target Price $40

Futu NewsNov 20 19:31

H.C. Wainwright Maintains Kyverna Therapeutics(KYTX.US) With Hold Rating, Cuts Target Price to $6

Futu NewsNov 20 19:31

Analysts Offer Insights on NA Companies: Viking Holdings Ltd (VIK), Kyverna Therapeutics, Inc. (KYTX) and Amer Sports, Inc. (AS)

TipRanksNov 20 19:25

Kyverna Therapeutics Is Maintained at Overweight by Wells Fargo

Dow JonesNov 16 03:23

Kyverna Therapeutics Analyst Ratings

BenzingaNov 16 03:14

Wells Fargo Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Cuts Target Price to $24

Futu NewsNov 15 21:37

Morgan Stanley Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Maintains Target Price $40

Futu NewsNov 14 20:34

Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Mural Oncology Plc (MURA) and Copa Holdings (CPA)

TipRanksNov 14 20:03

UBS Initiates Kyverna Therapeutics(KYTX.US) With Buy Rating, Announces Target Price $13

Futu NewsOct 11 21:33

Kyverna Therapeutics Initiated at Buy by UBS

Dow JonesOct 10 21:45

Kyverna Therapeutics Price Target Announced at $13.00/Share by UBS

Dow JonesOct 10 21:45

Kyverna Therapeutics Analyst Ratings

BenzingaOct 10 21:35

Rodman & Renshaw Initiates Kyverna Therapeutics(KYTX.US) With Buy Rating, Announces Target Price $16

Futu NewsOct 10 16:34

Kyverna Therapeutics Analyst Ratings

BenzingaSep 19 18:57

HC Wainwright & Co. Reiterates Neutral on Kyverna Therapeutics, Maintains $7 Price Target

BenzingaSep 19 18:57

Morgan Stanley Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Maintains Target Price $40

Futu NewsSep 19 18:31

H.C. Wainwright Maintains Kyverna Therapeutics(KYTX.US) With Hold Rating, Maintains Target Price $7

Futu NewsSep 19 18:31

Morgan Stanley Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Maintains Target Price $40

Futu NewsSep 17 19:31

J.P. Morgan Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Maintains Target Price $33

Futu NewsSep 13 18:31

Kyverna Therapeutics Analyst Ratings

BenzingaAug 15 19:28